References
1. Greenwood J P, Maredia N, Younger J F, Brown J M, Nixon J, Everett C
C, et al. Cardiovascular magnetic resonance and single-photon emission
computed tomography for diagnosis of coronary heart disease (CE-MARC): a
prospective trial. Lancet . 2012; 379(9814): 453-60.
2. Rastam S, Al Ali R, Maziak W, Mzayek F, Fouad F M, O’Flaherty M, et
al. Explaining the increase in coronary heart disease mortality in Syria
between 1996 and 2006. BMC Public Health . 2012;
12:(754):754.
3. Heran B S, Chen J M, Ebrahim S, Moxham T, Oldridge N, Rees K, et al.
Exercise-based cardiac rehabilitation for coronary heart disease.Cochrane Database Syst Rev . 2011; 7): CD001800.
4. Muhammad N, et al. . Anti-miR-203 suppresses ER-positive breast
cancer growth and stemness by targeting SOCS3. Oncotarget . 2016;
7(36): 58595-58605.
5. Shimono Y, et al., . MicroRNA Regulation of Human Breast Cancer Stem
Cells. . J Clin Med, . 2015.; Dec 25;5(1): pii: E2.
6. Feng J, Huang S, He M, Dai X, Li J, Deng Q, et al. [Analysis on the
association of single nucleotide polymorphism in the promoter region of
pre-miR-320b-2 with coronary heart disease risk and factors influencing
circulating microRNA-320b level]. Zhonghua Yu Fang Yi Xue
Za Zhi . 2014; 48(10): 893-9.
7. Miller C L, Haas U, Diaz R, Leeper N J, Kundu R K, Patlolla B, et al.
Coronary heart disease-associated variation in TCF21 disrupts a miR-224
binding site and miRNA-mediated regulation. PLoS Genet .
2014; 10(3): e1004263.
8. Nabialek E, Wanha W, Kula D, Jadczyk T, Krajewska M, Kowalowka A, et
al. Circulating microRNAs (miR-423-5p, miR-208a and miR-1) in acute
myocardial infarction and stable coronary heart disease.Minerva Cardioangiol . 2013; 61(6): 627-37.
9. Huang X, Ding L, Bennewith K L, Tong R T, Welford S M, Ang K K, et
al. Hypoxia-inducible mir-210 regulates normoxic gene expression
involved in tumor initiation. Mol Cell . 2009; 35(6):
856-67.
10. Mutharasan R K, Nagpal V, Ichikawa Y,Ardehali H. microRNA-210 is
upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent
pathways and exerts cytoprotective effects. Am J Physiol
Heart Circ Physiol . 2011; 301(4): H1519-30.
11. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan M A, et al.
MicroRNA-210 as a novel therapy for treatment of ischemic heart
disease. Circulation . 2010; 122(11 Suppl): S124-31.
12. Kim H W, Haider H K, Jiang S,Ashraf M. Ischemic preconditioning
augments survival of stem cells via miR-210 expression by targeting
caspase-8-associated protein 2. J Biol Chem . 2009;
284(48): 33161-8.
13. Kuo H F, Liu P L, Chong I W, Liu Y P, Chen Y H, Ku P M, et al.
Pigment Epithelium-Derived Factor Mediates Autophagy and Apoptosis in
Myocardial Hypoxia/Reoxygenation Injury. PLoS One . 2016;
11(5): e0156059.
14. Liu H, Huan L, Yin J, Qin M, Zhang Z, Zhang Z, et al. Role of
microRNA-130a in myocardial hypoxia/reoxygenation injury.Exp Ther Med . 2017; 13(2): 759-765.
15. Liang W, Guo J, Li J, Bai C,Dong Y. Downregulation of miR-122
attenuates hypoxia/reoxygenation (H/R)-induced myocardial cell apoptosis
by upregulating GATA-4. Biochem Biophys Res Commun . 2016;
478(3): 1416-22.
16. Li R, Geng H H, Xiao J, Qin X T, Wang F, Xing J H, et al. miR-7a/b
attenuates post-myocardial infarction remodeling and protects H9c2
cardiomyoblast against hypoxia-induced apoptosis involving Sp1 and
PARP-1. Sci Rep . 2016; 6(29082.
17. Huang X,Zuo J. Emerging roles of miR-210 and other non-coding RNAs
in the hypoxic response. Acta Biochim Biophys Sin
(Shanghai) . 2014; 46(3): 220-32.
18. He B, Zhao Y, Xu L, Gao L, Su Y, Lin N, et al. The nuclear melatonin
receptor RORalpha is a novel endogenous defender against myocardial
ischemia/reperfusion injury. J Pineal Res . 2016; 60(3):
313-26.
19. Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y, et al.
Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis
mediator and contributes to myocardial ischaemia/reperfusion
injury. Eur Heart J . 2013; 34(24): 1834-45.
20. Huang X, Le Q T,Giaccia A J. MiR-210–micromanager of the hypoxia
pathway. Trends Mol Med . 2010; 16(5): 230-7.
21. Nie Y, Han B M, Liu X B, Yang J J, Wang F, Cong X F, et al.
Identification of MicroRNAs involved in hypoxia- and serum
deprivation-induced apoptosis in mesenchymal stem cells.Int J Biol Sci . 2011; 7(6): 762-8.
22. Yang W, Sun T, Cao J, Liu F, Tian Y,Zhu W. Downregulation of
miR-210 expression inhibits proliferation, induces apoptosis and
enhances radiosensitivity in hypoxic human hepatoma cells in
vitro. Exp Cell Res . 2012; 318(8): 944-54.
23. Gou D, Ramchandran R, Peng X, Yao L, Kang K, Sarkar J, et al.
miR-210 has an antiapoptotic effect in pulmonary artery smooth muscle
cells during hypoxia. Am J Physiol Lung Cell Mol Physiol .
2012; 303(8): L682-91.
24. Kim H W, Mallick F, Durrani S, Ashraf M, Jiang S,Haider K H.
Concomitant activation of miR-107/PDCD10 and hypoxamir-210/Casp8ap2 and
their role in cytoprotection during ischemic preconditioning of stem
cells. Antioxid Redox Signal . 2012; 17(8): 1053-65.
25. Ma S, Wang Y, Chen Y,Cao F. The role of the autophagy in myocardial
ischemia/reperfusion injury. Biochimica et biophysica
acta . 2015; 1852(2): 271-276.
26. Hamacher-Brady A, Brady N R,Gottlieb R A. The interplay between
pro-death and pro-survival signaling pathways in myocardial
ischemia/reperfusion injury: apoptosis meets autophagy.Cardiovascular drugs and therapy . 2006; 20(6): 445-462.
27. Joubert P E, Werneke S W, de la Calle C, Guivel-Benhassine F,
Giodini A, Peduto L, et al. Chikungunya virus-induced autophagy delays
caspase-dependent cell death. J Exp Med . 2012; 209(5):
1029-47.